ThirtyFiveBio

Private

AbingdonHealthcare & Life Scienceshttps://www.thirtyfivebio.com/

Last Round

VC Round

Apr 15, 2025

Total Funding Raised

$21.44M

Company Overview

ThirtyFiveBio is a biotechnology company developing first-in-class small-molecule inhibitors of G protein-coupled receptor 35 (GPR35) to treat severe gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall molecule inhibitorsGPR35 antagonistsulcerative colitisinflammatory bowel diseaseIBDgut epithelial shieldpreclinical researchbiotech startupgastroenterologytherapeutic developmentdrug pipelinebiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ThirtyFiveBio Comps

Public and private peers based on sector, stage, and business model.

ThirtyFiveBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ThirtyFiveBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 15, 2025
Grant	Jul 2, 2024
Grant	Sep 13, 2023

View all Funding Rounds

ThirtyFiveBio Investors

Notable investors and investment history

ThirtyFiveBio investors
Investor	Rounds
Innovate UK	Grant
AbbVie Ventures	VC Round
Innovate UK	Grant
Canaan Partners	Seed, VC Round
Mayewell Capital	VC Round

View all Investors

ThirtyFiveBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ThirtyFiveBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ThirtyFiveBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon

Employee Range15

Year Founded2021

Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.